Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure allows for selective functionalization, making it valuable in creating active pharmaceutical ingredients (APIs) for targeted cancer therapies. Commonly employed in cross-coupling reactions due to the bromopyrimidine moiety, facilitating the formation of carbon-carbon and carbon-heteroatom bonds in drug discovery research. Also utilized in agrochemical research for designing novel bioactive molecules.